November 1, 2024: FDA Issues Letter Warning People About Compounded GLP-1 Drugs As more pharmacies compound GLP-1 drugs for weight loss, the FDA issued a warning to patients who take these versions of GLP-1 drugs
If you smoke, they can recommend resources to help you cut back and quit
These alterations ultimately shift the volume-pressure relationship in the left ventricle, contributing to clinical heart failure
Subgroup analyses indicated that this risk was particularly elevated in individuals receiving high-dose treatment, in studies of long-acting agents, and in overweight/obese populations
JoinSkinny Side Effects and Safety Questions to Discuss With a Provider Side effects vary by the specific medication, dose, and formulation a provider prescribes, so this article won't assign safety data from an FDA-approved branded drug to an unidentified compounded formulation - that's a conversation for you and your provider